Pyridines and derivatives (total related compounds in database) |
|
|
3,3'-(1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn]-3,8-phenanthroline-2,7-diyl)dipropanoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Eriksson J, et al. 2012. Adv Exp Med Biol |
|
5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid |
Depiction based on curated SMILES
N
N
HO
O
CH
3
S
|
Escherichia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Pan NJ, et al. 2009. Antimicrob Agents Chemother
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.
|
Back to top |
|